Tradestie Institutional Equity Comparison Engine

EQ vs ENTX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ENTX Overall Edge

ENTX Captures Institutional Edge (2โ€“1 Pillars ยท 4โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Entera Bio Ltd. Ordinary Shares (ENTX) driven by superior Momentum & Technical, Options & Structure while EQ counters with relative strength in Valuation. Fundamentally, EQ trades at 1.5x Forward P/E with 0.0% operating margin (-52.3% YoY revenue) versus ENTX at N/M Forward P/E and 0.0% operating margin (-100.0% YoY). In options structure, EQ sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro) against ENTX sits in CONSOLIDATION (33rd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner EQ
EQ 1.5x vs ENTX N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin 0.0% vs 0.0% ยท YoY -52.3% vs -100.0%
Momentum & Technical Winner ENTX
1Y +5.0% vs +24.7% ยท 52W Pos 9% vs 73%
Options & Structure Winner ENTX
UNCLASSIFIED (100th %ile IV) vs CONSOLIDATION (33rd %ile IV)
EQ NASDAQ
Equillium, Inc. Common Stock
Pharmaceutical Preparations
$1.06
-5.36% 1D
Market Cap $92.2M
1M Return -16.54%
1Y Return +4.95%
Forward P/E 1.5x
Unified AI Score
48.6 / 100 HOLD
Tech 29.0 Fund 55.0 Flow 63.0 Mom 60.0
ENTX NASDAQ
Entera Bio Ltd. Ordinary Shares
Biological Products, (No Disgnostic Substances)
$3.31
+0.76% 1D
Market Cap $571.2M
1M Return +9.44%
1Y Return +24.72%
Forward P/E N/M
Unified AI Score
47.5 / 100 HOLD
Tech 52.0 Fund 49.0 Flow 72.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: EQ +4.95% ENTX +24.72% Spread: +19.77 pp (ENTX Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period EQ Revenue ENTX Revenue EQ Op. Margin ENTX Op. Margin Margin Edge
FY2020 N/A $0M N/A -3059.7% ENTX
FY2021 N/A $0M N/A -2139.6% ENTX
FY2022 $20M $0M -393.9% -9714.2% EQ
FY2023 $40M N/A -40.2% N/A EQ
FY2024 $40M $0M -20.1% -5295.6% EQ
FY2025 N/A $0M N/A -27450.0% ENTX

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: EQ (4) vs ENTX (4)
Institutional Metric EQ ENTX Criterion Row Winner
Market Capitalization Scale $92.2M $571.2M Larger Scale ENTX
Trailing P/E Ratio Valuation 1.5x N/M Lower Multiple EQ
Forward P/E Ratio Valuation 1.5x N/M Lower Multiple EQ
Revenue Growth (YoY) Growth -52.3% -100.0% Higher Growth EQ
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -59.0% -20.3% Higher ROE ENTX
52-Week Range Position Momentum 9% ($1โ€“$4) 73% ($1โ€“$4) Stronger Trend ENTX
Beta / 30D Volatility Risk Regime 1.54ฮฒ ยท 89% Vol 0.92ฮฒ ยท 53% Vol Lower Realized Risk ENTX
Unified Institutional Score Composite Signal 48.6 / 100 (HOLD) 47.5 / 100 (HOLD) Higher Composite EQ

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full EQ vs ENTX Buy Guide
EQ UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live EQ Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ENTX CONSOLIDATION
83d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 33rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ENTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither EQ nor ENTX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.